AKT1 and hepatocellular carcinoma: Studies have shown that in HCC cells such as HepG2 and SMMC-7721, FKA directly binds to CXCL12, blocking the CXCL12/CXCR4 signaling pathway and inhibiting PI3K/Akt phosphorylation.